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1. Introduction 
It has been demonstrated that the hypothalamic 
growth hormone (GH) release inhibiting factor, 
somatostatin, also suppresses glucose induced insulin 
release in man [1-3] and in the isolated perfused 
pancreas from the dog [1] and rat [4,5]. In the 
latter preparation the lowest effective dose of soma- 
tostatin was 1 ng/ml of perfusate. By increasing the 
dose to 100 ng/ml, an almost complete inhibition of 
basal as well as stimulated insulin release was observed. 
On the other hand, somatostatin i  concentrations up
to 200 ng/ml did not influence glucose stimulated 
insulin release from isolated rat islets [4]. 
The present study demonstrates that somatostatin 
in very high concentrations suppressed the effect of 
glucose on insulin release. Furthermore, the accumu- 
lation of cyclic AMP, shown in previous tudies to 
occur in response to the hexose [6], was concomi- 
tantly diminished. 
2. Materials and methods 
Pancreatic slets were isolated from fed male 
Sprague-Dawley rats (150-200g) by a modified 
collagenase t chnique [6]. After isolation under a 
stereomicroscope th islets were preincubated in 
Krebs-Henseleit bicarbonate buffer (KHB) containing 
2 mg/ml of bovine albumin, 0.6 mg/ml of glucose, 
and 100/aCi of [3H] 2-adenine for 60 min at 37°C 
under continuous gasing with CO2:02 (5:95%). After 
the preincubation period the islets were washed four 
times. Groups of 15 islets each were selected under 
the microscope and transferred to incubation tubes 
containing KHB. The incubations were started by the 
addition of the test agents. The final volume of 
incubations was 1.0 ml. Incubations were carried out 
in duplicates or triplicates. The phosphodiesterase 
inhibitor, 3-isobutyl-l-methylxanthine (IBMX), was 
included in a concentration f 0.1 mM in all incuba- 
tions. At the end of the incubation period a portion 
of the media was removed, after which the incuba- 
tions were terminated by immersing the tubes in boil- 
ing water for 3 min. [3H]cyclic AMP was purified by 
ion-exchange chromatography and barium sulfate 
precipitation [7]. Insulin was measured radioimmuno- 
logically using a double antibody system [8]. 
Crude collagenase was purchased from Worthington 
Biochemical Corporation (Freehold, N. J., USA), 
bovine albumin (Fraction V) from Armour Co. 
(Eastboume, UK), IBMX from Aldrich Co. (Melwauker; 
Wis., USA). Cyclized somatostatin a d rat insulin were 
generous gifts of Dr R. Guillemin, The Salk Institute 
(La Jolla, Calif., USA) and Dr J. Schlichtkrull, Novo 
Research Institute (Copenhagen, Denmark). [3 H] 2- 
adenine with the specific acitivty of 31.7 Ci/mmol 
was obtained from New England Nuclear (Dreiecken- 
hein, West Germany). 
North-Holland Publishing Company - Amsterdam 131 
Volume 55, number 1 FEBS LETTERS July 1975 
Table 1 
Effect of somatostatin o glucose induced insulin release 
from isolated rat islets after 60 rain of incubation 
(#U insulin/islet; mean ± S.E.M. of 7 complete xperiments) 
Glucose Somatostatin ( g/ml) 
(mg/ml) 
0 500 1 250 
0.6 2.1 ± 0.4 3.8 ± 0.7 - 
1.5 20.7 ± 7.3 11.2 ± 4.7* - 
5.0 111.4 ± 15.8 108.0 ± 13.0 91.0 ± 9.0 
* p < 0.02 (Students t-test for paired ifferences) 
3. Results 
As seen in table 1, somatostatin (500 ng/ml) 
significantly inhibited only insulin release induced by 
the intermediate concentration of glucose used, 1.5 
mg/ml, and not that induced by 5.0 mg/ml. The 
decrease in insulin release was about 45% (p<0.02). 
Insulin release to the highest concentration of glucose 
was not influenced even by as high a concentration of
somatostatin as 1250 ng/ml. 
The corresponding results concerning [3 H]cyclic 
AMP accumulation i the incubation media and in 
the islets are presented in table 2. The medium con- 
tent of the cyclic nucleotide was increased 2.5- and 
6-fold by glucose in the concentrations 1.5 and 5.0 
ng/ml, respectively. A lesser effect was obtained with 
these amounts of  glucose on the cyclic AMP content 
of the islets, the stimulation ow amounting to 
1.6- and 2.5-fold. The addition of somatostatin 
(500 ng/ml) - as in the case of insulin release - was 
accompanied by a significant inhibition of cyclic AMP 
accumulation i the medium only in the presence of 
1.5 mg/ml of glucose. This inhibition amounted to 
40% (p<0.02). No significant effect was noted on the 
tissue level of the nucleotide. Again, 1250 ng/ml of 
somatostatin had no effect on cyclic AMP in the 
medium or islets in the presence of 5.0 mg/ml of 
glucose. 
4. Discussion 
There is ample evidence that somatostatin hibits 
insulin release induced by glucose [1 -5 ] ,  glucagon 
[9], isoproterenol [10], theophylline [10] and 
tolbutamide [9]. All these insulinogogues have in 
common stimulation of production of cyclic AMP in 
the islets. Therefore, it could be suggested that soma- 
tostatin exerts its effect on insulin secretion by way 
of a decrease in the intracellular level of the nucleo- 
tide. This idea is strongly supported by the present 
finding that somatostatin parallelly inhibited glucose 
stimulated insulin release and the accumulation of 
[3 H] cyclic AMP in the incubation medium of rat 
islets. 
No significant effect was obtained with somatos- 
tatin on the content of [3 H]cyclic AMP in the islets. 
This difference in the level of cyclic AMP in the 
medium and the tissue under the influence of soma- 
tostatin most likely has to do with the time of incu- 
bation. During prolonged incubation - as in the present 
experiments - changes in cyclic AMP in the medium 
reflect the activity of the adenyl cyclase-cycl ic AMP 
system during the entire incubation period. In contrast. 
Table 2 
Effect of somatostatin o glucose induced accumulation of [3 H] cyclic AMP in isolated rat islets 
and their incubation media after 60 min of incubation (dpm/islet; mean ± S.E.M. of 7 complete 
experiments) 
Islet Medium 
Glucose Somatostatin ng/ml Somatostatin ng/ml 
mg/mI 0 500 1 250 0 500 1 250 
0.6 13.4±2.1 12.6±2.7 - 9.9±4.4 6.9±1.8 - 
1.5 22.7±4.4 16.5±2.0 - 25.5±6.9 15.2±4.6" - 
5.0 32.9±6.9 21.7±3.0 20.7±2.6 56.9±10.1 43.4±6.9 40.4±2.8 
* p < 0.02 (Students t-test for paired differences). 
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the accumulation of  cyclic AMP in the islets only 
reflects hort time events, since the turnover of the 
nucleotide in the islets is very rapid [6]. 
In the present study, the accumulation of [all]- 
cyclic AMP was measured after a prelabeUing 
procedure. However, it has been demonstrated 
previously that this measurement corresponds to the 
total amount of the nucleotide when this is deter- 
mined by the protein kinase binding method [6]. 
In a previous paper we were unable to inhibit 
glucose stimulated insulin release from rat islets with 
200 ng/ml of somatostatin [4]. In the present 
experiments, the administration of 500 ng/ml was 
accompanied by a definite inhibition of insulin release. 
In both sets of experiment the glucose dose was 
1.5 mg/ml. Somatostatin the dosages 500 and 
1250 ng/ml exerted no significant effect on either 
insulin release or cyclic AMP accumulation i the 
presence of as high a glucose concentration as 
5.0 mg/ml. This favors the idea, suggested earlier [5], 
that somatostatin hibits glucose induced insulin 
release in a competitive way. 
We have recently demonstrated, by use of  immuno- 
histochemical technique, that considerable amounts 
of somatostatin or a somatostatin-like p ptide are 
accumulated in the islets of Langerhans of rats and 
guinea-pigs [11 ]. Against this background, the present 
finding that somatostatin hibits glucose induced 
accumulation of cyclic AMP indicates a physiological 
role for somatostatin the regulation of cyclic AMP 
in the endocrine pancreas. In this context it is of 
interest hat somatostatin also inhibits cyclic AMP 
accumulation i isolated cells of the hypophysis [ 12, 
13]. 
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